Skip to main content
logo
Atrium Therapeutics, Inc. (RNA)
NASDAQ: RNA · Real-Time Price · USD
14.19
-0.41 (-2.81%)
At close: Sep 4, 2026, 4:00 PM EDT
14.18
-0.01 (-0.07%)
After-hours: Sep 4, 2026, 7:30 PM EDT

Atrium Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Accounts Receivable
---0.75
Other Receivables
-0.1--
Receivables
-0.1-0.75
Prepaid Expenses
4.511.540.480.11
Other Current Assets
6.331.21--
Total Current Assets
275.052.850.480.86
Property, Plant & Equipment
5.365.516.79.44
Total Assets
280.518.357.1910.29

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Accounts Payable
3.514.40.530.5
Accrued Expenses
17.278.691.441.5
Current Portion of Leases
1.683.673.843.64
Current Unearned Revenue
9.0421.6420.9928.16
Other Current Liabilities
-3.4--
Total Current Liabilities
31.5141.826.833.8
Long-Term Leases
--2.966.21
Long-Term Unearned Revenue
33.6528.6937.9640.9
Other Long-Term Liabilities
0.780.570.57-
Total Liabilities
65.9471.0768.2980.91

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Common Stock
0.02-62.71-61.11-70.62
Shareholders' Equity
214.58-62.71-61.11-70.62
Total Liabilities & Equity
280.518.357.1910.29

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Total Debt
1.683.676.89.85
Net Cash (Debt)
262.22-3.67-6.8-9.85
Net Cash Growth
----
Net Cash Per Share
15.33-0.24--
Filing Date Shares Outstanding
17.1115.51--
Total Common Shares Outstanding
17.1115.51--
Working Capital
243.54-38.96-26.32-32.95
Book Value Per Share
12.54-4.04--
Tangible Book Value
214.58-62.71-61.11-70.62
Tangible Book Value Per Share
12.54-4.04--
Machinery
-5.572.031.76
Leasehold Improvements
--0.290.29